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Endovascular suture versus cutdown for
endovascular aneurysm repair: A prospective
randomized pilot study
Giovanni B. Torsello, MD,a Bernd Kasprzak, MD,a Eckhard Klenk, MD,a Jo¨rg Tessarek, MD,a
Nani Osada, PhD,b and Giovanni F. Torsello,a Mu¨nster, Germany
Purpose: To evaluate safety and cost benefits of the percutaneous technique for treatment of aortic aneurysm, a
prospective randomized study was performed that compared the endovascular suture technique with conventional
cutdown access and repair.
Materials and Methods: From January 2002 through July 2002, 30 endografts, including 14 Talent stent-grafts
(Medtronic, Sunrise, Fla) and 16 Zenith endografts (Cook, Bloomington, Ind) were implanted in 30 patients for
endovascular aneurysm treatment. The patients were randomized to either percutaneous technique (group A) or
conventional cutdown (group B). Fifty-five femoral arteries were cannulated with large-bore (14F-25F) introducers and
were included in the study. Safety and efficiency of both techniques were assessed by recording the complication rates,
operation time, discharge, and time to ambulation. Comparison of selected estimated costs included both variable and
fixed costs for femoral access and expenses for treatment of complications.
Results: No operative deaths occurred. The complication rates were similar and included 1 arterial thrombosis in each
group, 3 lymphoceles in group B, and 1 conversion to cutdown because of bleeding in group A. Mean surgery time
(86.7 27 minutes vs 107.8 38.5 minutes; P < .05) and time to ambulation (20.1 4.3 hours vs 33.1 18.4 hours;
P < .001) were significantly shorter in the group treated percutaneously. Because of the cost of the closure device, total
cost of the percutaneous technique averaged 99.2 € more than cutdown.
Conclusions: The percutaneous technique decreases the invasiveness of endovascular therapy of aortic aneurysm and
reduces operative time and time to ambulation. Complications were roughly equivalent in severity. The additional cost for
the device appears to justify its use for this form of aneurysm treatment. (J Vasc Surg 2003;38:78-82.)
Access to the femoral artery during endovascular aneu-
rysm repair is commonly achieved with open femoral inci-
sion. With endovascular suture devices and the “pre-close”
application technique, it is possible to repair aortic aneu-
rysms totally percutaneously.1-4 Even with large-bore (up
to 27F) introducer sheaths, aortic aneurysms can be treated
without surgical cutdown of the femoral arteries.5 Both
surgical dissection and percutaneous vascular suturing have
associated morbidity. Paresthesia, lymphoceles, and healing
disorders are frequent complications of wounds in the
groin. The scars make repeat interventions to treat en-
doleak or graft occlusion more difficult. On the other hand,
false aneurysm and arterial thrombosis are typical compli-
cations of percutaneous techniques.6
Until now, no randomized studies have been published
comparing the two techniques for treatment of aortic an-
eurysm. Therefore we undertook a prospective randomized
trial to compare the efficacy and safety of totally percutane-
ous access and surgical exposure of the femoral artery in
patients undergoing endovascular aneurysm repair.
METHODS
Between January and July 2002, 30 consecutive pa-
tients (29 men) with mean age of 72.9  9.9 years (range,
51-90 years) underwent endovascular repair of an aneu-
rysm of the abdominal aorta (n 28) or thoracic aorta (n
2). The patients were randomized to either percutaneous
technique (n 15; group A) or surgical cutdown (n 15;
group B) for femoral access of sheaths 14F or larger. The
study protocol was approved by the human ethics commit-
tee of our institution. Written and oral consent was ob-
tained from the patients before inclusion in the trial. All
patients were considered candidates for the study, includ-
ing those with calcification of the femoral artery, scar in the
groin, or obesity. Exclusion criteria (psychiatric patients,
patients undergoing implantation of an aortomonoiliac
endograft, patients with an aneurysm of the femoral artery)
were set, but no patients with these characteristics were
treated during the study period. Twenty-eight procedures
were performed after administration of spinal anesthesia,
and 2 were performed with the patient under general
anesthesia. Sixteen aneurysms were excluded with the Ze-
nith graft (Cook, Bloomington, Ind), and 14 with the
Talent endovascular graft (Medtronic, Sunrise, Fla). All
procedures were performed by four experienced vascular
surgeons. All investigators had performed more than 30
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endovascular sutures with Prostar XL before the start of the
study.
Fifty-five femoral arteries (27 in group A, 28 in group
B) cannulated with a sheath 14F or larger were considered
for the study (Table I). In 5 cases a straight aortic graft was
implanted without the necessity of using a large-bore intro-
ducer for the contralateral leg. Since conventional compres-
sion techniques for the contralateral approach were used in
these cases, 5 femoral arteries were not included in the
study.
In group A (percutaneous technique) one 10F Prostar
XL percutaneous vascular surgery device (Perclose, Red-
wood City, Calif) was used in the “pre-close” technique for
closure of the access site, as described.1-4,7
According to this technique, deployment of the suture
is performed at the beginning of the procedure, ensuring
that the needles penetrates the arterial wall before the
arteriotomy is enlarged by introduction of sheaths larger
than 10F.
Arterial access was achieved with an 18-gauge needle by
introducing an 8F sheath. Over a 0.035 inch nonhydro-
philic guide wire, the sheath was exchanged for a 10F
Prostar XL. After removing the Prostar catheter and before
introduction of the graft, a 12F or 14F sheath for dilation of
the vessel at the access site was inserted. The endograft was
then implanted as usual, after removal of the 14F sheath
over a Lunderqvist guide wire with manual compression of
the groin.
In the patients randomized to surgical cutdown (group
B) a transverse groin incision was made, to expose the
common femoral artery for direct needle puncture. Proxi-
mal and distal control of the vessel was obtained with vessel
loops and vascular clamps. After the sheath was removed,
the artery was repaired with fine polypropylene sutures.
Vacuum drains were placed in the incision, which was
closed in layers.
All patients received a bolus of 5000 IU of heparin after
sheath insertion. No protamine was given at the end of the
procedure. Duplex ultrasound scanning of the groin was
performed before and after the operation. Preoperative
computed tomography included imaging of the groin to
assess calcifications or aneurysm of the common femoral
artery. Decreases in hemoglobin and hematocrit were used
as an indicator of blood loss. Both parameters were mea-
sured 1 day before and 1 day after the procedure. Efficiency
and safety were measured by surgery time and time to
ambulation, as well as by frequency of local complications
(Table II). Total duration of the procedure and hospital
costs for vascular access and surgical treatment of groin
complications were calculated by the hospital administra-
tion and expressed in euros (in July 2002, 1 US dollar
equaled approximately 1 euro).
The difference in hospital costs between the two tech-
niques was estimated in terms of the variable costs (Prostar
device and instrumentation costs for cutdown) and fixed
costs (costs for surgery and anesthesia per minute). Oper-
ation time in minutes (“skin-to-skin”) was multiplied by
the average surgeon (0.96 €/min), anesthesiologist (0.85
€/min), and nurse (0.40 €/min) salary. Costs assumed to
be the same for both procedures (eg, basic instrumentation,
diagnostic evaluation, grafts and catheters, patient medica-
tion, recovery room) were not considered in this partial
comparison of estimated costs.
The Mann-Whitney U test was used for comparison of
nonparametric variables. Complications were analyzed with
the Fisher exact test.
Categorical variables are expressed as frequency and
percentage, whereas continuous variables are presented as
mean SD. Differences were considered significant at P
.05.
RESULTS
Of the 30 patients enrolled in the study, 15 were
randomized to receive percutaneous treatment (group A)
and 15 to undergo the cutdown procedure (group B). In all
patients, endovascular treatment was successfully per-
formed, with no in-hospital deaths. Analysis of basic patient
characteristics (gender, age, obesity) and of the data for the
graft used (type, diameter of both graft and introducer
sheath) showed no significant differences between groups
(Table I). As evidence of successful randomization, no
significant differences were found in fluoroscopy time
(17.4 6.6 minutes in group A vs 19 15.1 in group B).
In 1 patient (3.7%) the Prostar device was unsuccessful
in closing the arterial entry site, and conversion to an open
groin incision was necessary. Since the guide wire was
previously removed, temporary hemostasis could not be
achieved with a balloon catheter. Applying gentle compres-
sion above the inguinal ligament, the bleeding was treated
with arterial suturing. For better identification of the leak,
the endovascular suture was left in place.
In all patients in group A, only one Prostar device was
used. In 3 patients device failure was observed, caused by
deflection of needles through a calcified femoral artery in 1
patient and failure of the needles to grasp the arterial wall in






Age (y) 74.5  10.4 71  9.6
Obesity 6 7
Main body (mm) 29.2  3.8 29.6  4
Contralateral leg (mm) 15.4  3.4 15.1  2.1
Talent stent-graft 9 5
Zenith stent-graft 6 10
Sutured arteries 27 28
14F sheath 4 8
16F sheath 3 2
18F sheath 9 5
20F sheath 4 8
22F sheath 1 3
24F sheath 6 1
25F sheath 0 1
Sheath (mean diameter) 19  3.4 18.2  3.3
Values represent number or mean  SD.
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2 obese patients. In all cases, a second device was used
without late complications.
Distal embolization or dissection of the arterial wall was
not observed during the study. Since the device is a mono-
rail system, the wire was usually removed before the wire
entry port passed under the skin. Because of tortuosity of
the aorta in 2 patients, it was not possible to pass the J-loop
tip of the catheter into the aorta after removing the wire. In
these patients we left the wire in situ to prevent damage to
the vessel wall or distal embolization.
Wound complications consisted of three lymphoceles
(cutdown group), which did not require specific treatment
and healed completely. Postoperative femoral occlusion
developed in 1 patient in each group and was treated
successfully with surgical thrombectomy.
Surgical repair of the access artery was necessary in 2
patients in group A, because of bleeding in 1 and arterial
thrombosis in the other (13%), and in 1 patient in group B,
because of arterial thrombosis (6.6%). The cause of femoral
occlusion was intimal damage after clamping in 1 patient in
group B and after mobilization of a calcified plaque inward
by the large sheath in 1 patient in group A.
The percutaneous technique did not significantly re-
duce the amount of blood loss, although a trend toward
decreased hemoglobin (10%) and hematocrit (8%) was
noted in group A (Table II). Blood transfusion or surgical
repair because of secondary hemorrhage was not necessary
in either group. No pseudoaneurysm in either group was
observed.
Mean operation time (107.8 38.5 minutes vs 86.7
27 minutes; P .05) and time to ambulation (33.1 19.4
hours vs 20.1  4.3 hours; P  .001) were significantly
longer in the conventional treatment (cutdown) group.
Cost of materials for femoral access in group A (Prostar
device and treatment of complications) was significantly
higher than in group B (223.6 63.8 € vs 18.0 0 €; P
.001), but the percutaneous technique significantly re-
duced hospital resource use (mean cost for use of operating
room, 251.2  89 € in group A vs 357.6  153.3 €; P 
.01) compared with the cutdown approach. Despite these
differences, the combined additional cost averaged 99.2 €
more in the percutaneous group, mainly because of the cost
of the catheter itself (474.7 109.7 € vs 375.5 153.3 €;
P  .01).
DISCUSSION
Access to the femoral artery in the endovascular treat-
ment of aortic aneurysm is commonly achieved with oper-
ative femoral cutdown. This minor surgical procedure is
sometimes associated with postprocedural groin complica-
tions and patient discomfort.8
In addition, necessity for repeat intervention after en-
dovascular aneurysm repair is high,9 and the transfemoral
approach is most frequently used. Avoidance of open fem-
oral exposure can thus decrease risk for inguinal complica-
tions after repeat operations and femoral puncture in a
scarred groin.
New technology allows arteriotomy repair with a per-
cutaneous suture device even after use of large-bore intro-
ducers.1-4,7,10 In an attempt to perform aneurysm repair
without any open component, the feasibility of percutane-
ous access, also after using sheaths up to 27F, was analyzed
in a nonrandomized study.5
The success rate with the percutaneous technique
ranged between 71.4% and 96%, depending on patient










Howell et al1 16 144 94.4
Traul et al3 16 14 71.4
Traul et al3 22 12 75
Haas et al7 16-22 13 100
Teh et al2 16-22 82 85
Torsello et al5 14-27 145 93.8
Howell et al11 16-22 60 96





Surgery time (min) 86.7  27 107.8  38.5 .05
Fluoroscopy time (min) 17.4  6.6 19  15.1 NS
Time to ambulation (hr) 20.1  4.3 33.1  19.4 .001
Hemoglobin loss (g/100 mL) 2.0  0.7 2.2  0.9 NS
Hematocrit loss (%) 6.0  2.5 6.5  2.1 NS
Arterial thrombosis 1 1 NS
Primary hemostasis 26/27 28/28 NS
Need for vascular repair 2 1 NS
Pseudoaneurysm/blood transfusion 0 0 —
Paresthesia/infection 0 0 —
Lymphocele 0 3 NS
Mean access material cost (Euro) 223.6  63.8 18  0 .001
Mean OR usage cost (Euro) 251.2  89 357.6  153.3 .01
Values represent numbers or mean  SD.
OR, Operating room; NS, not significant.
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volume and selection (Table III). Obesity, calcified femoral
arteries, scarred groin, and kinking of both iliac arteries and
aorta were the main risk factors for failure of the device to
close the arteriotomy,2,3,5,6 requiring conversion to an
open groin incision. In addition, patients with small and
diseased femoral arteries are not good candidates for per-
cutaneous vascular suturing after use of large-bore sheaths.
Since abundant subcutaneous fat makes the advancement
of the device difficult, obesity is also an important risk
factor. Because of difficulty in creating an adequate subcu-
taneous tunnel for the hub of the device, the needles failed
to grasp the arterial wall in 2 obese patients in this study.
While testing the free run of the sutures, a tear in the vessel
wall was detected. With the guide wire left in place, a
second device was inserted, and the sutures were deployed
successfully.
In 1 patient severe calcification of the femoral artery
caused deflection of the nitinol needles, which did not enter
the barrel of the device. Pushing the handle back into the
hub of the device did not correct the problem; thus con-
version to open incision was performed to remove the
needles.
Factors leading to failure of the procedure are not only
patient-related or device-related, but also depend on the
expertise of the operating team. We found that the compli-
cation rate decreased with increasing experience with the
device.5 Since the suture material is multifilament polyes-
ter, it is important to irrigate the sutures well to ensure free
knot slippage down to the arteriotomy.
Former experience with the use of two percutaneous
closure devices showed that the presence of too many
threads can cause catching on other sutures, disrupting the
vessel wall during fastening of the knot. Use of only one
device did not increase the rate of bleeding complications in
this study.
Appropriate puncture and suture technique is manda-
tory. If the puncture is too caudal there is risk for introduc-
ing the large-bore sheath through the superficial femoral
artery or through the profunda, increasing the risk for
damage to the vessel.5
With the percutaneous technique, bleeding sometimes occurs from needle holes or from gaps between sutures. Minor
bleeding can generally be stopped by using a knot pusher to ensure approximation of the knot to the arterial wall. If
primary hemostasis cannot be obtained, a PTFE felt pledget can be used as a patch and sewn with the sutures of the
Prostar device.
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In cases of tortuous aorta or iliac artery, we introduce
the Prostar catheter under fluoroscopic guidance to control
the position of both the guide wire and the catheter to
prevent dissection and distal embolization. If necessary, we
do not remove the guide wire even after the wire entry port
has passed under the skin. Angiography is recommended in
patients in whom difficulties are encountered during place-
ment of the closure device. In cases of leak due to tearing of
sutures through a diseased arterial wall, we use manual
compression or a polytetrafluoroethylene felt pledget patch
attached with the four vascular sutures of the Prostar device
(Figure).
In summary, endovascular suturing enables completely
percutaneous repair of aortic aneurysm. After initial scepti-
cism due to user and device failure, at our institution
complete percutaneous repair has become the approach of
first choice to treat aortic aneurysm in patients considered
candidates for endovascular treatment. Arterial exposure
(cutdown procedure) is used only in patients with occlusive
or aneurysmal disease of the femoral artery or requiring
aortomonoiliac grafting. The operative costs of the new
technique are higher because of the purchase price of the
device. Nevertheless, the procedure is less invasive, is time-
saving, and may result in shorter convalescence after endo-
vascular repair of aortic aneurysm.
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